Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Johnson & Johnson Could Level Up With Its $16.8 Billion Purchase of Abiomed
Johnson & Johnson Could Level Up With Its $16.8 Billion Purchase of Abiomed
Johnson & Johnson Could Level Up With Its $16.8 Billion Purchase of Abiomed
Submitted by
admin
on November 10, 2022 - 10:33am
Source:
Motley Fool
News Tags:
JNJ
Medtech
devices
Abiomed
M&A
Headline:
Johnson & Johnson Could Level Up With Its $16.8 Billion Purchase of Abiomed
snippet:
Massachusetts-based Abiomed manufactures heart pumps.
Johnson & Johnson can easily afford this acquisition despite the hefty price tag.
Abiomed's growth outlook should help J&J, but it could take years.
Do Not Allow Advertisers to Use My Personal information
